grant

Protein phosphorylation and growth factor function

Organization UNIVERSITY OF CALIFORNIA, SAN DIEGOLocation LA JOLLA, UNITED STATESPosted 1 Aug 1994Deadline 30 Jun 2026
NIHUS FederalResearch GrantFY2024AddressAutoregulationBindingBody TissuesCancer TreatmentCancersCell BodyCell Communication and SignalingCell SignalingCell membraneCellsCellular ExpansionCellular GrowthCytoplasmic MembraneDataDevelopmentG Protein-Complex ReceptorG Protein-Coupled Receptor GenesG-Protein-Coupled ReceptorsGPCRGene TranscriptionGenetic TranscriptionGoalsGrowth AgentsGrowth FactorGrowth SubstancesHomeostasisHumanInositide PhospholipidsInositol PhosphoglyceridesInositol PhospholipidsIntracellular Communication and SignalingKinasesMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMediatingMembraneMerlinModelingModern ManMoesin-Ezrin-Radixin-Like ProteinMolecularMolecular InteractionNF2NF2 Gene ProductNF2 geneNatural CompoundNeurofibromatosis 2 Gene ProductNeurofibromatosis 2 GenesNeurofibromatosis Type 2 ProteinNeurofibromin 2Organ SizeOsmosisPI Transfer ProteinPathway interactionsPhosphatidyl InositolPhosphatidyl Inositol PhosphatesPhosphatidylinositol Exchange ProteinPhosphatidylinositol PhosphatesPhosphatidylinositol Transfer ProteinPhosphatidylinositolsPhosphoinositidesPhosphorylationPhosphotransferase GenePhosphotransferasesPhysiological HomeostasisPlasma MembranePlayPolyphosphoinositidesProtein PhosphorylationProteins Growth FactorsPtdInsRNA ExpressionRegulationRoleSamplingSchwannomerlinSchwannominSchwannomin ProteinSignal PathwaySignal TransductionSignal Transduction SystemsSignalingSiteStressTCGATestingThe Cancer Genome AtlasTherapeuticTherapeutic InterventionTissuesTranscriptionTransphosphorylasesanti-cancer therapybiological signal transductioncancer therapycancer-directed therapycell growthdevelopmentalhuman diseaseintervention therapymalignancymembrane structurenaturally occurring compoundneoplasm/cancernf 2 Genesnovelpathwayplasmalemmaprotein functionscreeningscreeningssensorsmall moleculesocial roletumor
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary/Abstract
The emerging Hippo pathway plays a major role in development, cell growth, tissue homeostasis, and

organ size. Dysregulation of Hippo pathway contributes to human diseases, most notably cancer. TCGA study

with analysis of over nine thousand human tumor samples has revealed that Hippo is one of the nine signals

pathways that are frequently altered and contributes to human cancer. The Hippo pathway consists a kinase

cascade that phosphorylates and inhibits the downstream transcription module of YAP/TAZ. A wide range of

signals have been discovered to modulate the Hippo pathway. However, the precise mechanism of Hippo

pathway regulation, particularly how upstream signals feed into the Hippo kinase cascade, is largely unknown.

The major goal of this proposal is to understand the fundamental mechanism of Hippo pathway regulation. By

screening for natural compounds to modulate the Hippo pathway, we have discovered that microcolin B (MCB)

potently activates the Hippo kinases. Our preliminary study indicates that MCB directly targets

phosphatidylinositol transfer protein (PITP) to activate the Hippo pathway. PITP functions to transfer

phosphatidylinositol from ER, the site of synthesis, to other compartment membranes, particularly plasma

membrane, in the cell. Our preliminary data suggest an exciting and novel model that phosphatidylinositol

metabolites play a key role in Hippo regulation. We further propose that NF2, which is a key upstream regulator

of the Hippo pathway and can bind phosphatidylinositol phosphates (PIPs), may mediate the PIP signal to Hippo

regulation. This proposal aims to demonstrate the function and mechanism of phosphatidylinositol and its

metabolites in Hippo regulation and how PIPs mediate upstream signals to Hippo. Further, completion of this

project will provide exciting scientific basis of using small molecules to target the Hippo pathway for YAP

dependent cancer.

Grant Number: 5R01GM051586-29
NIH Institute/Center: NIH

Principal Investigator: JOAN BROWN

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →